LLY
Eli Lilly and Company (LLY)
Last Price$837.6(0.6%)
Market Cap$756.9B

LLY Q4’24 Earnings

MetricEstimatesActualsSurprise
Revenue$13.5B$13.5B
BEAT by 0.4%
EPS$5.04$4.88
MISS by 3.3%

LLY Earnings Calls

Latest LLY Earnings Call Summary

Crunching data... Almost there!

LLY Earnings Calls Top Focus Area

Crunching data... Almost there!

LLY Earnings Sentiment

LLY Earnings Sentiment Score

Crunching data... Almost there!

LLY Earnings Sentiment & Price Performance

Crunching data... Almost there!

LLY Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$2,000.0M$4,000.0M$6,000.0M$8,000.0M$10.0B$12.0B$14.0BApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$5,859.8M$5,740.6M$6,805.6M$6,772.8M$7,810.0M$6,941.6M$6,960.0M$9,498.6M$8,768.0M$11.4B
Value Sense
Actual Revenue
Forecast Revenue

LLY Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$4,644.7M$4,978.7M$4,959.7M$5,375.6M$4,865.1M$5,404.8M$5,191.7M$5,760.5M$5,228.3M$5,824.3M$5,658.0M$6,160.7M$5,700.0M$6,355.2M$6,061.9M$6,438.6M$5,092.2M$5,636.7M$5,476.6M$6,114.0M$5,859.8M$5,499.4M$5,740.6M$7,440.0M$6,805.6M$6,740.1M$6,772.8M$7,999.9M$7,810.0M$6,488.0M$6,941.6M$7,301.8M$6,960.0M$8,312.1M$9,498.6M$9,353.4M$8,768.0M$11.3B$11.4B$13.5B
Revenue estimate$4,110.8M$4,110.8M$4,110.8M$4,110.8M$4,982.3M$4,982.3M$4,982.3M$4,982.3M$5,121.6M$5,121.6M$5,121.6M$5,121.6M$4,185.9M$4,185.9M$4,185.9M$4,185.9M$5,198.9M$5,584.3M$5,495.7M$5,914.5M$5,492.1M$5,763.5M$5,875.2M$7,267.5M$6,932.2M$6,595.3M$6,639.4M$7,687.5M$7,287.1M$6,848.9M$6,887.8M$7,332.5M$6,863.5M$7,582.7M$8,967.1M$8,946.3M$8,935.8M$9,981.5M$12.1B$13.5B
Revenue surprise13.0%21.1%20.6%30.8%2.4%8.5%4.2%15.6%2.1%13.7%10.5%20.3%36.2%51.8%44.8%53.8%2.1%0.9%0.3%3.4%6.7%4.6%2.3%2.4%1.8%2.2%2.0%4.1%7.2%5.3%0.8%0.4%1.4%9.6%5.9%4.6%1.9%13.2%5.4%0.4%
EPS actual$0.50$0.57$0.75$0.43$0.42$0.71$0.74$0.70($0.10)$0.96$0.53($1.59)$1.16($0.25)$1.13$1.06$4.33$1.44$1.37$1.56$1.60$1.56$1.33$2.21$1.49$1.53$1.22$1.81$2.11$1.06$1.61$2.04$1.49$1.96($0.06)$2.31$2.49$3.29$1.08$4.88
EPS estimate$0.67$0.67$0.67$0.67$0.87$0.87$0.87$0.87$0.94$0.94$0.94$0.94$0.92$0.92$0.92$0.92$1.31$1.45$1.40$1.52$1.48$1.56$1.71$2.37$2.12$1.89$1.96$2.45$2.29$1.70$1.91$1.78$1.73$1.98($0.18)$2.30$2.47$2.74$1.42$5.04
EPS surprise25.4%14.9%11.9%35.8%51.7%18.4%14.9%19.5%110.6%2.1%43.6%269.1%26.1%127.2%22.8%15.2%230.9%0.7%2.4%2.5%8.1%0.1%22.3%6.7%29.7%19.2%37.8%26.0%8.0%37.7%15.9%14.4%13.7%1.0%64.3%0.6%1.0%20.0%24.0%3.3%

LLY Price Change after Earnings

Crunching data... Almost there!

LLY Recent Quarter Financial Statements Overview

Income statement
Balance sheet
Cash Flow statement
$13.5B 44.7% YoY
$11.1B 44.6% YoY
82.2% margin
Cost of revenue
$2,403.8M 44.9% YoY
Operating income
$5,148.8M 67.3% YoY
38.0% margin
Other: $70.3M
Net interest: $180.4M
Operating expenses
$5,980.2M 29.5% YoY
Pre-tax income
$5,038.7M 100.8% YoY
37.2% margin
Net income
$4,409.8M 101.4% YoY
32.6% margin
Income tax
$628.9M
12.5% tax rate
R&D
$3,211.7M 25.3% YoY
23.7% of revenue
SG&A
$2,424.5M 26.0% YoY
17.9% of revenue

Competing with LLY Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$756.9B
$45.0B
$11.74
44.7%
111.3%
Beat by 11.9%
Beat by 243.4%
(5.8%)
(4.1%)
Beats: 6
Misses: 4
31.8%
94.5%
$393.8B
$88.8B
$6.70
5.3%
(14.9%)
Beat by 1.6%
Miss by 35.2%
(3.9%)
85.3%
Beats: 9
Misses: 1
1.4%
81.3%
$370.7B
$56.3B
$2.41
5.6%
N/A
Beat by 5.7%
Miss by 100.6%
(14.3%)
(13,968.4%)
Beats: 8
Misses: 2
5.6%
407.8%
$342.3B
DKK 290.4B
DKK 22.67
30.1%
28.9%
Beat by 19.3%
Beat by 6.0%
(3.4%)
1.7%
Beats: 6
Misses: 4
24.6%
23.6%
$236.6B
$64.2B
$6.74
6.8%
N/A
Miss by 5.2%
Miss by 0.9%
0.1%
44.7%
Beats: 8
Misses: 2
1.6%
33.1%
$232.9B
$54.1B
$4.54
23.8%
59.0%
Beat by 13.9%
Miss by 5.0%
(7.7%)
14.2%
Beats: 5
Misses: 5
6.0%
(0.8%)
$222.8B
$51.1B
$5.92
15.1%
(65.7%)
Beat by 6.0%
Miss by 26.7%
(4.1%)
45.0%
Beats: 9
Misses: 1
2.3%
39.5%
$170.8B
$33.4B
$7.61
10.9%
(18.9%)
undefinedN/A
undefinedN/A
(11.0%)
269.7%
Beats: 8
Misses: 2
5.3%
173.6%
$148.9B
$63.6B
$1.41
24.7%
N/A
Beat by 19.0%
Miss by 88.6%
(18.5%)
911.0%
Beats: 10
Misses: 0
(1.1%)
108.5%
$142.6B
€44.3B
€4.45
(66.7%)
N/A
Miss by 42.0%
Miss by 67.9%
31.0%
104.5%
Beats:
Misses:
11.6%
(4.7%)

FAQ

1. When was Eli Lilly and Company's last earnings date?

Eli Lilly and Company's last earnings date was Dec'24 (Q4 2024).

2. What is Eli Lilly and Company's EPS, and was there a surprise?

3. What is Eli Lilly and Company's revenue, and was there a surprise?

4. What is Eli Lilly and Company's next quarter EPS estimate?

Eli Lilly and Company's next quarter EPS estimate is $4.60, with an expected 78.3% YoY growth.